December 10, 2009
UW Medicine’s Institute of Translational Health Sciences presents Breast Cancer Screening – The New Guidelines: Can We Make Sense Out of the Controversy?
WHO: Alfred O. Berg, M.D., M.P.H., Professor, Family Medicine, Family Medicine Research Section, Former Chairman, United States Preventive Services Task Force
Joann G. Elmore, M.D., M.P.H. (Moderator), Professor of Medicine, Section Head, Division of General Internal Medicine, Harborview Medical Center
Paul Fishman, Ph.D., Associate Investigator, Group Health Research Institute, Affiliate Associate Professor, Health Services
Constance Lehman, M.D., Ph.D., Professor, Radiology, Director of Breast Imaging, Seattle Cancer Care Alliance
Diana L. Miglioretti, Ph.D., Senior Investigator, Group Health Research Institute, Affiliate Associate Professor, Biostatistics
WHAT: An interdisciplinary panel of researchers and providers will discuss the controversy surrounding the new breast cancer screening guidelines. In November, the U.S. Preventive Services Task Force released new guidelines regarding breast cancer screening. The delivery of the guidelines, coupled with intense media attention, has generated confusion among patients, health care professionals and lawmakers. A national debate over how to interpret the guidelines is ongoing.
WHEN: Thursday, December 17, 2009 — 12:00 p.m. to 1:30 p.m.
WHERE: Hogness Auditorium, Warren G. Magnuson Health Sciences Center
University of Washington, 1959 N.E. Pacific Street, Seattle, WA 98195
Note: The Institute of Translational Health Sciences at UW Medicine is a cross-institutional organization that includes UW Medicine, Fred Hutchinson Cancer Research Center, Group Health Research Institute and Seattle Children’s.
# # #
